CHANGE-POINTS IN THE SERIES OF T4 COUNTS PRIOR TO AIDS

被引:52
作者
KIUCHI, AS
HARTIGAN, JA
HOLFORD, TR
RUBINSTEIN, P
STEVENS, CE
机构
[1] YALE UNIV,DEPT BIOSTAT,NEW HAVEN,CT 06510
[2] NEW YORK BLOOD CTR,NEW YORK,NY 10012
关键词
EM ALGORITHM; EMPIRICAL BAYES; HIERARCHICAL BAYES; MARKOV CHAIN MONTE CARLO;
D O I
10.2307/2533329
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The absolute number of T4 cells has been established as an important clinical marker of disease progression to acquired immunodeficiency syndrome (AIDS) in persons infected with human immunodeficiency virus (HIV). Series of T4 counts are analyzed from the 131 homosexual men who entered the New York Blood Center Study in 1984, mostly seropositive for HIV, and who developed AIDS as participants by 1990. These series exhibit a gradual decline of the log(T4) count followed by a more rapid decline close to the time of the development of AIDS. Empirical Bayes and hierarchical Bayes change point models are proposed to estimate the distribution of the time before AIDS when this rapid decline begins. Results using the EM Algorithm and Markov chain Monte Carlo indicate that the mean change point occurs approximately 1 year before diagnosis with a standard deviation of 9 months. Detection of a change point may indicate that an AIDS diagnosis is increasingly likely for an individual HIV-positive but AIDS-free.
引用
收藏
页码:236 / 248
页数:13
相关论文
共 27 条
[21]   GRAPHS AND STOCHASTIC RELAXATION FOR HIERARCHICAL BAYES MODELING [J].
LANGE, N .
STATISTICS IN MEDICINE, 1992, 11 (14-15) :2001-2016
[22]  
LANGE N, 1992, J AM STAT ASSOC, V87, P615, DOI 10.2307/2290194
[23]  
MELBYE M, 1987, CURRENT TOPICS AIDS, V1, P57
[24]  
ODELL PL, 1966, J AM STAT ASSOC, V61, P198
[25]   HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III INFECTION IN A COHORT OF HOMOSEXUAL MEN IN NEW-YORK-CITY [J].
STEVENS, CE ;
TAYLOR, PE ;
ZANG, EA ;
MORRISON, JM ;
HARLEY, EJ ;
DECORDOBA, SR ;
BACINO, C ;
TING, RCY ;
BODNER, AJ ;
SARNGADHARAN, MG ;
GALLO, RC ;
RUBINSTEIN, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (16) :2167-2172
[26]   HEPATITIS-B VACCINE - DEMONSTRATION OF EFFICACY IN A CONTROLLED CLINICAL-TRIAL IN A HIGH-RISK POPULATION IN THE UNITED-STATES [J].
SZMUNESS, W ;
STEVENS, CE ;
HARLEY, EJ ;
ZANG, EA ;
OLESZKO, WR ;
WILLIAM, DC ;
SADOVSKY, R ;
MORRISON, JM ;
KELLNER, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (15) :833-841
[27]  
TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114